MDxHealth SA — Form SCHEDULE 13D/A
Filed October 15, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
▼ Likely negative
significance 28/100
What the filing says
A Schedule 13D/A filer (insider) executed 14 tranches of share dispositions totaling 972,361 shares between September 17 and October 13, 2026, at prices ranging from $0.5104 to $0.6733 per share, representing approximate gross proceeds of ~$569K–$590K. The filing reports these sales but does not name the seller or disclose their remaining beneficial ownership position.
Why this rating
Stock trading at <$0.70 indicates microcap scale; ~1M share dump ~$569K is notable but company size unknown. Insider selling pressure in weak-priced stock suggests low confidence; timing and volume are modest-sized routine disclosures.
See more from October 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.